Haris Jahić

1.3k total citations
13 papers, 994 citations indexed

About

Haris Jahić is a scholar working on Molecular Biology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Haris Jahić has authored 13 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Molecular Medicine and 5 papers in Pharmacology. Recurrent topics in Haris Jahić's work include Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Cancer therapeutics and mechanisms (3 papers). Haris Jahić is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Cancer therapeutics and mechanisms (3 papers). Haris Jahić collaborates with scholars based in United States, Brazil and Russia. Haris Jahić's co-authors include David E. Ehmann, Rong-Fang Gu, Stewart L. Fisher, Grant K. Walkup, Philip L. Ross, Jun Hu, Günther Kern, Ning Gao, Thomas F. Durand-Réville and Sushmita D. Lahiri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Haris Jahić

13 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haris Jahić United States 10 810 503 295 262 147 13 994
Jason Thresher United States 12 656 0.8× 406 0.8× 258 0.9× 275 1.0× 125 0.9× 19 892
Melissa D. Barnes United States 16 777 1.0× 490 1.0× 182 0.6× 255 1.0× 193 1.3× 22 928
Thomas F. Durand-Réville United States 16 795 1.0× 445 0.9× 252 0.9× 236 0.9× 137 0.9× 20 1.1k
Kirk Nelson United States 16 905 1.1× 555 1.1× 320 1.1× 266 1.0× 218 1.5× 23 1.2k
R.A. Powers United States 19 854 1.1× 461 0.9× 395 1.3× 229 0.9× 67 0.5× 33 1.1k
Corey Fyfe United States 12 510 0.6× 304 0.6× 235 0.8× 162 0.6× 135 0.9× 16 840
Ruslan Tsivkovski United States 15 890 1.1× 522 1.0× 205 0.7× 250 1.0× 222 1.5× 16 1.0k
Sachin Bhagwat India 19 638 0.8× 530 1.1× 227 0.8× 220 0.8× 190 1.3× 47 1.0k
Michiyoshi Nukaga Japan 18 893 1.1× 407 0.8× 398 1.3× 237 0.9× 70 0.5× 38 1.2k
Michele Johnstone United States 10 540 0.7× 325 0.6× 229 0.8× 152 0.6× 105 0.7× 13 738

Countries citing papers authored by Haris Jahić

Since Specialization
Citations

This map shows the geographic impact of Haris Jahić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haris Jahić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haris Jahić more than expected).

Fields of papers citing papers by Haris Jahić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haris Jahić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haris Jahić. The network helps show where Haris Jahić may publish in the future.

Co-authorship network of co-authors of Haris Jahić

This figure shows the co-authorship network connecting the top 25 collaborators of Haris Jahić. A scholar is included among the top collaborators of Haris Jahić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haris Jahić. Haris Jahić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Cottrell, Kevin M., Douglas A. Whittington, Kimberly J. Briggs, et al.. (2025). MTA-Cooperative PRMT5 Inhibitors: Mechanism Switching Through Structure-Based Design. Journal of Medicinal Chemistry. 68(4). 4217–4236. 3 indexed citations
2.
Cottrell, Kevin M., Kimberly J. Briggs, Douglas A. Whittington, et al.. (2024). Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with MTAP-Deleted Cancers. Journal of Medicinal Chemistry. 67(8). 6064–6080. 34 indexed citations
3.
Shapiro, Adam B., Ning Gao, Haris Jahić, et al.. (2017). Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514. ACS Infectious Diseases. 3(11). 833–844. 52 indexed citations
4.
Murphy-Benenato, Kerry E., Thomas F. Durand-Réville, Andrew D. Ferguson, et al.. (2015). SAR and Structural Analysis of Siderophore-Conjugated Monocarbam Inhibitors of Pseudomonas aeruginosa PBP3. ACS Medicinal Chemistry Letters. 6(5). 537–542. 24 indexed citations
5.
Lahiri, Sushmita D., Stefano Mangani, Haris Jahić, et al.. (2014). Molecular Basis of Selective Inhibition and Slow Reversibility of Avibactam against Class D Carbapenemases: A Structure-Guided Study of OXA-24 and OXA-48. ACS Chemical Biology. 10(2). 591–600. 90 indexed citations
6.
Murphy-Benenato, Kerry E., Hongming Wang, Helen M. McGuire, et al.. (2013). Identification through structure-based methods of a bacterial NAD+-dependent DNA ligase inhibitor that avoids known resistance mutations. Bioorganic & Medicinal Chemistry Letters. 24(1). 360–366. 10 indexed citations
7.
Ehmann, David E., Haris Jahić, Philip L. Ross, et al.. (2013). Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases. Journal of Biological Chemistry. 288(39). 27960–27971. 301 indexed citations
8.
Ehmann, David E., Haris Jahić, Philip L. Ross, et al.. (2012). Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitor. Proceedings of the National Academy of Sciences. 109(29). 11663–11668. 410 indexed citations
9.
Jahić, Haris, et al.. (2012). The kinetic mechanism of S. pneumoniae DNA ligase and inhibition by adenosine-based antibacterial compounds. Biochemical Pharmacology. 84(5). 654–660. 7 indexed citations
11.
Shapiro, Adam B., Stephania Livchak, Ning Gao, et al.. (2011). A Homogeneous, High-Throughput-Compatible, Fluorescence Intensity–Based Assay for UDP-N-Acetylenolpyruvylglucosamine Reductase (MurB) with Nanomolar Product Detection. SLAS DISCOVERY. 17(3). 327–338. 5 indexed citations
12.
Shapiro, Adam B., Haris Jahić, Swati Prasad, et al.. (2010). A Homogeneous, High-Throughput Fluorescence Anisotropy-Based DNA Supercoiling Assay. SLAS DISCOVERY. 15(9). 1088–1098. 24 indexed citations
13.
Deng, Gejing, Rong-Fang Gu, Stephen Marmor, et al.. (2004). Development of an LC–MS based enzyme activity assay for MurC: application to evaluation of inhibitors and kinetic analysis. Journal of Pharmaceutical and Biomedical Analysis. 35(4). 817–828. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026